Regeneration of sclerosed glomeruli : Mechanism of dedifferentiation and phenotypic changes in podocytes and induce redifferentiation.
硬化肾小球的再生:足细胞去分化和表型变化并诱导再分化的机制。
基本信息
- 批准号:17590818
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To monitor podocytes derived cells in the pathologic process of glomerular disease, we generate Nephrin-Cre/Rosa26 mice and then we crossed them with p21 deficient mice and induced anti-glomerular antibody glomerulonephritis. The kidney showed marked proteinuria coupled with glomerular epithelial hyperplasia. To analyze the origin and phenotype of these cells, immunohistochemistry for several podocytes markers and incorporation of BrdU was analyzed. Hypercellular lesions were virtually both LacZ and WT1 negative. In addition, we did not find out for LacZ+/WT1-cells or LacZ+/synaptopodin-cells. Thus podocytes dedifferentiation is not occurring in this setting of experimental glomerulonephritis.We are now investigating the plasticity of podocytes focusing on the function of nestin intermediate filament, neurogenic progenitor marker, we found nestin is predominantly expressed in the differentiated podocytes and cytoplasmic distribution of nestin is different from that of actin.siRNA of nestin for immortalized podocytes cell line reveals suppression of process formation suggesting nestin function for podocytes plasticity.
为了监测足细胞来源的细胞在肾小球疾病的病理过程中的作用,我们建立了Nephin-Cre/rosa26小鼠,并将它们与p21基因缺陷的小鼠杂交,诱导了抗肾小球抗体肾炎。肾脏有明显的蛋白尿,伴有肾小球上皮细胞增生。为了分析这些细胞的来源和表型,对几种足细胞标志物和BrdU的掺入进行了免疫组织化学分析。实质上,LacZ和WT1均为阴性的高细胞病变。此外,我们没有发现LacZ+/WT1-细胞或LacZ+/synaptopodin-细胞。因此,在这种实验性肾小球肾炎的情况下,足细胞不会发生去分化。我们目前正在研究足细胞的可塑性,重点是Nestin中间丝的功能,我们发现Nestin主要在分化的足细胞中表达,并且Nestin的细胞质分布不同于Actin。永生化的足细胞系的Nestin的siRNA显示突起形成的抑制,提示Nestin在足细胞可塑性中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGATA Michio其他文献
NAGATA Michio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGATA Michio', 18)}}的其他基金
Treatment of focal segmental glomerulosclerosis by Notch signaling inhibition
通过Notch信号抑制治疗局灶节段性肾小球硬化
- 批准号:
22590877 - 财政年份:2010
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glomerular remodeling and its application
肾小球重塑及其应用
- 批准号:
19590932 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of glomerulosclerosis on the basis of cell cycle reguration and differentiation of glomerular epithelial cells.
基于肾小球上皮细胞细胞周期调节和分化的肾小球硬化机制。
- 批准号:
10670154 - 财政年份:1998
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of angiotensin and bcl-2 on renal organogenesis.
血管紧张素和 bcl-2 对肾器官发生的作用。
- 批准号:
07670231 - 财政年份:1995
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Role of myosin 1e in podocyte biology and renal filtration
肌球蛋白 1e 在足细胞生物学和肾滤过中的作用
- 批准号:
10587345 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Mechanisms of Kidney Diseases Associated With APOL1 Variation
APOL1 变异相关肾脏疾病的机制
- 批准号:
10607630 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Regulation of NKCC2 and renal NaCl transport by protein-protein interactions
通过蛋白质-蛋白质相互作用调节 NKCC2 和肾脏 NaCl 转运
- 批准号:
10585141 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Covid-19 induced worsening of glomerular diseases
Covid-19 导致肾小球疾病恶化
- 批准号:
10655140 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy
靶向足细胞-内皮细胞串扰作为 FSGS 疗法
- 批准号:
10635547 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice
使用 BAC 转基因小鼠模拟 APOL1 高危活体供体的进行性慢性肾病的机制
- 批准号:
10726804 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
New Therapeutic Leads for Proteinuric Kidney Diseases
蛋白尿性肾病的新治疗方法
- 批准号:
10673944 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
The role of beta agonists in the treatment of chronic kidney disease
β受体激动剂在慢性肾脏病治疗中的作用
- 批准号:
10485842 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Molecular Determinants of Kidney Podocyte Architecture in Health, Injury, and Recovery
健康、损伤和恢复中肾足细胞结构的分子决定因素
- 批准号:
10659239 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:














{{item.name}}会员




